South Korea · Delayed Price · Currency is KRW NH Nongwoobio Statistics
Total Valuation
NH Nongwoobio has a market cap or net worth of KRW 111.57 billion. The enterprise value is 106.87 billion.
| Market Cap | 111.57B |
| Enterprise Value | 106.87B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
NH Nongwoobio has 16.03 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 16.03M |
| Shares Outstanding | 16.03M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 0.15% |
| Float | 6.73M |
Valuation Ratios
The trailing PE ratio is 9.11.
| PE Ratio | 9.11 |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 0.39 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | 22.48 |
| P/OCF Ratio | 11.91 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.92, with an EV/FCF ratio of 21.54.
| EV / Earnings | 8.72 |
| EV / Sales | 0.68 |
| EV / EBITDA | 5.92 |
| EV / EBIT | 9.33 |
| EV / FCF | 21.54 |
Financial Position
The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.48 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.48 |
| Debt / FCF | 5.40 |
| Interest Coverage | 11.49 |
Financial Efficiency
Return on equity (ROE) is 4.39% and return on invested capital (ROIC) is 3.87%.
| Return on Equity (ROE) | 4.39% |
| Return on Assets (ROA) | 2.03% |
| Return on Invested Capital (ROIC) | 3.87% |
| Return on Capital Employed (ROCE) | 3.88% |
| Weighted Average Cost of Capital (WACC) | 6.02% |
| Revenue Per Employee | 473.80M |
| Profits Per Employee | 36.79M |
| Employee Count | 333 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 0.69 |
Taxes
In the past 12 months, NH Nongwoobio has paid 1.30 billion in taxes.
| Income Tax | 1.30B |
| Effective Tax Rate | 9.59% |
Stock Price Statistics
The stock price has decreased by -16.75% in the last 52 weeks. The beta is 0.44, so NH Nongwoobio's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -16.75% |
| 50-Day Moving Average | 7,711.20 |
| 200-Day Moving Average | 8,131.15 |
| Relative Strength Index (RSI) | 41.49 |
| Average Volume (20 Days) | 43,322 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NH Nongwoobio had revenue of KRW 157.78 billion and earned 12.25 billion in profits. Earnings per share was 763.93.
| Revenue | 157.78B |
| Gross Profit | 75.65B |
| Operating Income | 11.45B |
| Pretax Income | 13.53B |
| Net Income | 12.25B |
| EBITDA | 18.04B |
| EBIT | 11.45B |
| Earnings Per Share (EPS) | 763.93 |
Balance Sheet
The company has 32.21 billion in cash and 26.79 billion in debt, with a net cash position of 5.42 billion or 338.41 per share.
| Cash & Cash Equivalents | 32.21B |
| Total Debt | 26.79B |
| Net Cash | 5.42B |
| Net Cash Per Share | 338.41 |
| Equity (Book Value) | 283.63B |
| Book Value Per Share | 17,637.31 |
| Working Capital | 162.24B |
Cash Flow
In the last 12 months, operating cash flow was 9.37 billion and capital expenditures -4.41 billion, giving a free cash flow of 4.96 billion.
| Operating Cash Flow | 9.37B |
| Capital Expenditures | -4.41B |
| Depreciation & Amortization | 6.59B |
| Net Borrowing | 190.00M |
| Free Cash Flow | 4.96B |
| FCF Per Share | 309.57 |
Margins
Gross margin is 47.95%, with operating and profit margins of 7.26% and 7.76%.
| Gross Margin | 47.95% |
| Operating Margin | 7.26% |
| Pretax Margin | 8.58% |
| Profit Margin | 7.76% |
| EBITDA Margin | 11.44% |
| EBIT Margin | 7.26% |
| FCF Margin | 3.15% |
Dividends & Yields
This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 3.13%.
| Dividend Per Share | 220.00 |
| Dividend Yield | 3.13% |
| Dividend Growth (YoY) | 13.64% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 28.79% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 3.09% |
| Earnings Yield | 10.98% |
| FCF Yield | 4.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NH Nongwoobio has an Altman Z-Score of 2.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 4 |